Ki-67 expression is predictive of prognosis in patients with stage I/II extranodal NK/T-cell lymphoma, nasal type

S. J. Kim, Byung Soo Kim, Chul Won Choi, Jung-Woo Choi, I. Kim, Y. H. Lee, Jun Suk Kim

Research output: Contribution to journalArticle

78 Citations (Scopus)

Abstract

Background: Localized extranodal natural killer (NK)/T-cell lymphoma, nasal type, commonly has a low or low-intermediate risk of the international prognostic index (IPI), so the IPI has shown inconsistency in predicting prognosis. Thus, we analyzed Ki-67 expression and proposed a new prognostic model including Ki-67 expression for stage I/II extranodal NK/T-cell lymphoma. Patients and methods: We studied Ki-67 expression and its relationship with prognosis in 50 patients with extranodal NK/T-cell lymphoma. Results: The patients were dichotomized by the median value: low (< 65%) versus high Ki-67 (≥ 65%). High Ki-67 was associated with a worse overall survival (OS; P = 0.021) and disease-free survival (DFS; P = 0.044). In multivariate analysis, Ki-67 expression and primary site of involvement were found to be an independent prognostic factor for OS and DFS (P < 0.05). Based on these results, we proposed a new clinico-pathological prognostic model with Ki-67 expression and the primary site of involvement. It showed a high degree of correlation with worse OS and DFS (P < 0.001). Conclusions: Ki-67 expression is predictive of prognosis, and our prognostic model may become a useful tool for predicting prognosis in patients with stage I/II extranodal NK/T-cell lymphoma, nasal type.

Original languageEnglish
Pages (from-to)1382-1387
Number of pages6
JournalAnnals of Oncology
Volume18
Issue number8
DOIs
Publication statusPublished - 2007 Aug 1

Fingerprint

Natural Killer T-Cells
T-Cell Lymphoma
Nose
Disease-Free Survival
Multivariate Analysis
Survival

Keywords

  • Extranodal lymphoma
  • Ki-67
  • NK/T cell
  • Prognosis

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Ki-67 expression is predictive of prognosis in patients with stage I/II extranodal NK/T-cell lymphoma, nasal type. / Kim, S. J.; Kim, Byung Soo; Choi, Chul Won; Choi, Jung-Woo; Kim, I.; Lee, Y. H.; Kim, Jun Suk.

In: Annals of Oncology, Vol. 18, No. 8, 01.08.2007, p. 1382-1387.

Research output: Contribution to journalArticle

@article{c48cce843c594d518b876c5e21efbae4,
title = "Ki-67 expression is predictive of prognosis in patients with stage I/II extranodal NK/T-cell lymphoma, nasal type",
abstract = "Background: Localized extranodal natural killer (NK)/T-cell lymphoma, nasal type, commonly has a low or low-intermediate risk of the international prognostic index (IPI), so the IPI has shown inconsistency in predicting prognosis. Thus, we analyzed Ki-67 expression and proposed a new prognostic model including Ki-67 expression for stage I/II extranodal NK/T-cell lymphoma. Patients and methods: We studied Ki-67 expression and its relationship with prognosis in 50 patients with extranodal NK/T-cell lymphoma. Results: The patients were dichotomized by the median value: low (< 65{\%}) versus high Ki-67 (≥ 65{\%}). High Ki-67 was associated with a worse overall survival (OS; P = 0.021) and disease-free survival (DFS; P = 0.044). In multivariate analysis, Ki-67 expression and primary site of involvement were found to be an independent prognostic factor for OS and DFS (P < 0.05). Based on these results, we proposed a new clinico-pathological prognostic model with Ki-67 expression and the primary site of involvement. It showed a high degree of correlation with worse OS and DFS (P < 0.001). Conclusions: Ki-67 expression is predictive of prognosis, and our prognostic model may become a useful tool for predicting prognosis in patients with stage I/II extranodal NK/T-cell lymphoma, nasal type.",
keywords = "Extranodal lymphoma, Ki-67, NK/T cell, Prognosis",
author = "Kim, {S. J.} and Kim, {Byung Soo} and Choi, {Chul Won} and Jung-Woo Choi and I. Kim and Lee, {Y. H.} and Kim, {Jun Suk}",
year = "2007",
month = "8",
day = "1",
doi = "10.1093/annonc/mdm183",
language = "English",
volume = "18",
pages = "1382--1387",
journal = "Annals of Oncology",
issn = "0923-7534",
publisher = "Oxford University Press",
number = "8",

}

TY - JOUR

T1 - Ki-67 expression is predictive of prognosis in patients with stage I/II extranodal NK/T-cell lymphoma, nasal type

AU - Kim, S. J.

AU - Kim, Byung Soo

AU - Choi, Chul Won

AU - Choi, Jung-Woo

AU - Kim, I.

AU - Lee, Y. H.

AU - Kim, Jun Suk

PY - 2007/8/1

Y1 - 2007/8/1

N2 - Background: Localized extranodal natural killer (NK)/T-cell lymphoma, nasal type, commonly has a low or low-intermediate risk of the international prognostic index (IPI), so the IPI has shown inconsistency in predicting prognosis. Thus, we analyzed Ki-67 expression and proposed a new prognostic model including Ki-67 expression for stage I/II extranodal NK/T-cell lymphoma. Patients and methods: We studied Ki-67 expression and its relationship with prognosis in 50 patients with extranodal NK/T-cell lymphoma. Results: The patients were dichotomized by the median value: low (< 65%) versus high Ki-67 (≥ 65%). High Ki-67 was associated with a worse overall survival (OS; P = 0.021) and disease-free survival (DFS; P = 0.044). In multivariate analysis, Ki-67 expression and primary site of involvement were found to be an independent prognostic factor for OS and DFS (P < 0.05). Based on these results, we proposed a new clinico-pathological prognostic model with Ki-67 expression and the primary site of involvement. It showed a high degree of correlation with worse OS and DFS (P < 0.001). Conclusions: Ki-67 expression is predictive of prognosis, and our prognostic model may become a useful tool for predicting prognosis in patients with stage I/II extranodal NK/T-cell lymphoma, nasal type.

AB - Background: Localized extranodal natural killer (NK)/T-cell lymphoma, nasal type, commonly has a low or low-intermediate risk of the international prognostic index (IPI), so the IPI has shown inconsistency in predicting prognosis. Thus, we analyzed Ki-67 expression and proposed a new prognostic model including Ki-67 expression for stage I/II extranodal NK/T-cell lymphoma. Patients and methods: We studied Ki-67 expression and its relationship with prognosis in 50 patients with extranodal NK/T-cell lymphoma. Results: The patients were dichotomized by the median value: low (< 65%) versus high Ki-67 (≥ 65%). High Ki-67 was associated with a worse overall survival (OS; P = 0.021) and disease-free survival (DFS; P = 0.044). In multivariate analysis, Ki-67 expression and primary site of involvement were found to be an independent prognostic factor for OS and DFS (P < 0.05). Based on these results, we proposed a new clinico-pathological prognostic model with Ki-67 expression and the primary site of involvement. It showed a high degree of correlation with worse OS and DFS (P < 0.001). Conclusions: Ki-67 expression is predictive of prognosis, and our prognostic model may become a useful tool for predicting prognosis in patients with stage I/II extranodal NK/T-cell lymphoma, nasal type.

KW - Extranodal lymphoma

KW - Ki-67

KW - NK/T cell

KW - Prognosis

UR - http://www.scopus.com/inward/record.url?scp=34548158504&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34548158504&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdm183

DO - 10.1093/annonc/mdm183

M3 - Article

VL - 18

SP - 1382

EP - 1387

JO - Annals of Oncology

JF - Annals of Oncology

SN - 0923-7534

IS - 8

ER -